Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD

Trial ID or NCT#

NCT00363298

Status

not recruiting iconNOT RECRUITING

Purpose

The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks.

Official Title

Double-blind Trial of Acute and Intermediate-term Dextro-amphetamine Versus Caffeine Augmentation in Treatment Resistant Obsessive Compulsive Disorder (OCD)

Eligibility Criteria

Ages Eligible for Study: 18 Years to 55 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Lorrin Koran

Contact us to find out if this trial is right for you.

Contact

Lorrin Koran
6507235154